IDXX

Q: What is the price of IDEXX Laboratories (IDXX) today?

The price of IDEXX Laboratories (IDXX) today is $ 635.66, with return of 40.39% compared to the last year. The price of IDEXX Laboratories (IDXX) started the year trading around $ 676.53 and today it is at $ 635.66. Follow the real-time price chart, the historical price of IDEXX Laboratories (IDXX) and international markets.

Q: When does IDEXX Laboratories (IDXX) pay dividends?

IDEXX Laboratories (IDXX) did not distribute dividends in the last year.

Q: Is IDEXX Laboratories (IDXX) worth it?

Currently, IDEXX Laboratories (IDXX) is priced at $ 635.66, with a P/E of 48.00%, representing a deviation of 4,787% from its historical average P/E. In the last year, the stock showed a variation of 40.39 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 40.39%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy IDEXX Laboratories (IDXX) stock?

Investing in stocks of IDEXX Laboratories (IDXX) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of IDEXX Laboratories (IDXX) yield today?

The yield of IDEXX Laboratories (IDXX) was -8.39% in the last month, 40.39% in the last year and 19.29% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of IDEXX Laboratories (IDXX) today, the total investment would be $ 63,566.00, based on the current price of $ 635.66.If past performance were to repeat, the return on your investment would be:In 1 year: $ 89,240.31In 5 years: $ 75,827.88In 10 years: $ 549,896.75It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

IDEXX Laboratories Inc.

Price

$ 635.66

return (12m)

40.39%

p/e

48.00

p/b

31.68

DIVIDEND YIELD

0.00%

price IDXX

IDXX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of IDXX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-8.39%

3 months

-15.49%

1 year

40.39%

2 years

10.30%

5 years

19.29%

10 years

765.08%

Fundamentals IDXX

review the fundamentals of IDEXX Laboratories shares

P/E

48.00

Sector: -2.14 Industry: -5.77

P/S (Price-to-Sales)

11.82

Sector: 2.06 Industry: 3.26

P/B

31.68

Sector: 2.34 Industry: 2.48

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

31.62%

Sector: -27.16% Industry: -52.92%

ROE

65.99%

Sector: -30.98% Industry: -45.34%

ROIC

38.39%

Sector: -421.19% Industry: -486.73%

NET MARGIN

24.62%

Sector: -29.07% Industry: -35.11%

GROSS MARGIN

61.80%

Sector: 44.34% Industry: 46.27%

OPERATING MARGIN

31.60%

Sector: -24.62% Industry: -30.73%

EV/EBITDA

34.62

Sector: -0.57 Industry: -4.16

EV/EBIT

37.32

Sector: -2.98 Industry: -5.86

PRICE-TO-ASSETS

15.18

Sector: 1.23 Industry: 1.46

BVPS

20.07

Sector: 3.47 Industry: 1.66

EPS

13.24

Sector: -0.90 Industry: -1.31

EQUITY-TO-ASSETS RATIO

0.48

Sector: 0.42 Industry: 0.46

LIABILITIES / ASSETS

0.52

Sector: 0.46 Industry: 0.43

CAGR REVENUE 5 YEARS

6.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

7.30%

Sector: - Industry: -

FAIR VALUE OF IDEXX Laboratories ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 635.66

Fair Value

$ 0.00

Upside Return potential.

-87.84%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals IDXX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/b	ROE	dy	market cap	net margin
LLY	43.78	37.88	86.53%	0.59%	$ 903.52 B	31.66%
ISRG	62.65	9.97	15.92%	0.00%	$ 178.94 B	28.38%
TMO	28.66	3.59	12.52%	0.34%	$ 192.11 B	15.05%
SNY	12.51	1.36	10.86%	4.73%	$ 114.14 B	18.68%
NVS	21.85	6.56	30.04%	2.43%	$ 305.57 B	24.67%
ABT	29.61	3.77	12.73%	2.12%	$ 193.15 B	14.72%
MDT	26.07	2.58	9.90%	2.92%	$ 124.17 B	13.71%
GSK	15.56	5.56	35.71%	2.82%	$ 118.68 B	17.48%
CVS	55.09	1.29	2.35%	3.47%	$ 97.40 B	0.44%
BSX	38.16	0.00	0.00%	0.00%	$ 110.60 B	14.44%
TMDX	49.74	12.85	25.84%	0.00%	$ 4.56 B	16.20%
HCA	17.89	-43.80	-244.82%	0.54%	$ 121.36 B	8.97%
DHR	40.98	2.82	6.88%	0.61%	$ 148.12 B	14.71%
RMD	25.46	5.99	23.51%	0.87%	$ 37.83 B	27.53%
INMD	10.22	1.40	13.73%	0.00%	$ 958.86 M	25.32%
FMS	17.45	0.87	5.00%	3.23%	$ 14.24 B	3.73%
PHG	27.73	2.24	8.06%	2.93%	$ 28.76 B	5.07%
SYK	44.76	6.48	14.48%	0.90%	$ 145.29 B	12.92%
CI	10.85	0.00	0.00%	2.15%	$ 74.56 B	2.50%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

IDXX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY IDEXX Laboratories

IDEXX Laboratories Inc.

Average user rating I10

4.0 (27 people)

United States

43 years

Founded: 1983

1991

Time since IPO - 35 years

10.350

Employees

The Company IDEXX Laboratories Inc. (United States), is listed on Nasdaq with a market value of $ 50.85 Billions, having an equity of $ 1.61 Billion.

With a total of 10.350 employees, the company is listed in the sector of Health and categorized in industry of Medical Supplies and Equipment.

In the last 12 months the Company had a revenue of $ 4.30 Billions, which generated a profit in the amount of $ 1.06 Billion.

As for its main indicators, the Company has a P/E ratio of 48.00, a P/BV ratio of 31.68 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker IDXX.

Market cap

$ 50.85 Billions

Net worth

$ 1.61 Billion

US$ 1,605,380,000.00

Assets

$ 3.35 Billions

US$ 3,350,760,000.00

Total Shares Outstanding

80.00 Millions

80,000,000

Average Daily Trading Volume

$ 502.89 Thousand

US$ 502,888.40

Sector

Health

Industry

Medical Supplies and Equipment

IDXX

IDXX revenue and profits

Financial Results IDXX

DRAG THE FRAME TO SEE MORE DATA

IDXX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/B

0.00

CVS - CVS Health

$ 76.69 25,42% (12M)

P/E

55.09

3.47%

ROE

2.35%

P/B

1.29

CI - Cigna

$ 280.31 --4,05% (12M)

P/E

10.85

2.15%

ROE

0.00%

P/B

0.00

CNC - Centene

$ 43.24 --25,03% (12M)

P/E

-3.19

0.00%

ROE

-33.28%

P/B

1.06

HUM - Humana

$ 189.83 --24,43% (12M)

P/E

17.64

1.86%

ROE

6.95%

P/B

1.23

HCA - HCA Healthcare

$ 532.30 69,76% (12M)

P/E

17.89

0.54%

ROE

-244.82%

P/B

-43.80

LLY - Eli Lilly

$ 1,009.52 15,58% (12M)

P/E

43.78

0.59%

ROE

86.53%

P/B

37.88

NVS - Novartis

$ 162.67 57,11% (12M)

P/E

21.85

2.43%

ROE

30.04%

P/B

6.56

LBPSW - 4D pharma

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-300.00%

P/VP

0.00

CVS - CVS Health

$ 76.69 25,42% (12 M)

P/L

55.09

3.47%

ROE

2.35%

P/VP

1.29

CI - Cigna

$ 280.31 --4,05% (12 M)

P/L

10.85

2.15%

ROE

0.00%

P/VP

0.00

CNC - Centene

$ 43.24 --25,03% (12 M)

P/L

-3.19

0.00%

ROE

-33.28%

P/VP

1.06

HUM - Humana

$ 189.83 --24,43% (12 M)

P/L

17.64

1.86%

ROE

6.95%

P/VP

1.23

HCA - HCA Healthcare

$ 532.30 69,76% (12 M)

P/L

17.89

0.54%

ROE

-244.82%

P/VP

-43.80

LLY - Eli Lilly

$ 1,009.52 15,58% (12 M)

P/L

43.78

0.59%

ROE

86.53%

P/VP

37.88

NVS - Novartis

$ 162.67 57,11% (12 M)

P/L

21.85

2.43%

ROE

30.04%

P/VP

6.56

Frequently Asked Questions

What is the price of IDEXX Laboratories (IDXX) today?

The price of IDEXX Laboratories (IDXX) today is $ 635.66, with return of 40.39% compared to the last year. The price of IDEXX Laboratories (IDXX) started the year trading around $ 676.53 and today it is at $ 635.66. Follow the real-time price chart, the historical price of IDEXX Laboratories (IDXX) and international markets.

When does IDEXX Laboratories (IDXX) pay dividends?

IDEXX Laboratories (IDXX) did not distribute dividends in the last year.

Is IDEXX Laboratories (IDXX) worth it?

Currently, IDEXX Laboratories (IDXX) is priced at $ 635.66, with a P/E of 48.00%, representing a deviation of 4,787% from its historical average P/E. In the last year, the stock showed a variation of 40.39 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 40.39%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy IDEXX Laboratories (IDXX) stock?

Investing in stocks of IDEXX Laboratories (IDXX) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of IDEXX Laboratories (IDXX) yield today?

The yield of IDEXX Laboratories (IDXX) was -8.39% in the last month, 40.39% in the last year and 19.29% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of IDEXX Laboratories (IDXX) today, the total investment would be $ 63,566.00, based on the current price of $ 635.66.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 89,240.31
In 5 years: $ 75,827.88
In 10 years: $ 549,896.75

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

IDXX

IDEXX Laboratories Inc.

Price

return (12m)

p/e

p/b

DIVIDEND YIELD

Return of IDXX

review the fundamentals of IDEXX Laboratories shares

P/E

P/S (Price-to-Sales)

P/B

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY IDEXX Laboratories

IDEXX Laboratories Inc.

United States

43 years

1991

10.350

PROFIT X PRICE IDXX

Financial Results IDXX

IDXX cash flow

asset growth - IDXX

IDXX balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

HCA - HCA Healthcare

LLY - Eli Lilly

NVS - Novartis

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

HCA - HCA Healthcare

LLY - Eli Lilly

NVS - Novartis

Frequently Asked Questions